Department of Radiation Sciences, Umeå University, Umeå, Sweden.
Cancer. 2011 Feb 15;117(4):714-22. doi: 10.1002/cncr.25650. Epub 2010 Sep 29.
The effectiveness of mammography screening for women ages 40 to 49 years still is questioned, and few studies of the effectiveness of service screening for this age group have been conducted.
Breast cancer mortality was compared between women who were invited to service screening at ages 40 to 49 years (study group) and women in the same age group who were not invited during 1986 to 2005 (control group). Together, these women comprise the Mammography Screening of Young Women (SCRY) cohort, which includes all Swedish counties. A prescreening period was defined to facilitate a comparison of mortality in the absence of screening. The outcome measure was refined mortality, ie, breast cancer death for women who were diagnosed during follow-up at ages 40 to 49 years. Relative risks (RRs) with 95% confidence intervals (CIs) were estimated.
There was no significant difference in breast cancer mortality during the prescreening period. During the study period, there were 803 breast cancer deaths in the study group (7.3 million person-years) and 1238 breast cancer deaths in the control group (8.8 million person-years). The average follow-up was 16 years. The estimated RR for women who were invited to screening was 0.74 (95% CI, 0.66-0.83), and the RR for women who attended screening was 0.71 (95% CI, 0.62-0.80).
In this comprehensive study, mammography screening for women ages 40 to 49 years was efficient for reducing breast cancer mortality.
对 40 至 49 岁女性进行乳房 X 光筛查的效果仍存在疑问,而且针对该年龄段人群进行服务性筛查的效果的研究甚少。
比较了在 1986 年至 2005 年期间被邀请参加 40 至 49 岁年龄段服务性筛查的女性(研究组)和未被邀请的同年龄段女性(对照组)之间的乳腺癌死亡率。这些女性共同构成了乳腺癌筛查年轻女性(SCRY)队列,包括瑞典所有的县。定义了一个预筛选期,以促进在没有筛查的情况下对死亡率进行比较。结局指标为精化死亡率,即 40 至 49 岁期间随访时诊断出的乳腺癌死亡。估计了相对风险(RR)及其 95%置信区间(CI)。
在预筛选期内,乳腺癌死亡率没有显著差异。在研究期间,研究组有 803 例乳腺癌死亡(730 万人年),对照组有 1238 例乳腺癌死亡(880 万人年)。平均随访时间为 16 年。被邀请参加筛查的女性的 RR 为 0.74(95%CI,0.66-0.83),参加筛查的女性的 RR 为 0.71(95%CI,0.62-0.80)。
在这项全面研究中,对 40 至 49 岁女性进行乳房 X 光筛查可有效降低乳腺癌死亡率。